LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 62 filers reported holding LEGEND BIOTECH CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 16,351 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 16,351 | -5.8% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 17,351 | -16.0% | 0.00% | -100.0% |
| Q4 2022 | $843 | -99.9% | 20,659 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $843,000 | -30.2% | 20,659 | -6.0% | 0.00% | -33.3% |
| Q2 2022 | $1,208,000 | +1.2% | 21,968 | -33.2% | 0.01% | +50.0% |
| Q1 2022 | $1,194,000 | -0.8% | 32,865 | +27.2% | 0.00% | 0.0% |
| Q4 2021 | $1,204,000 | +18.3% | 25,830 | +28.3% | 0.00% | 0.0% |
| Q3 2021 | $1,018,000 | -54.5% | 20,128 | -63.1% | 0.00% | 0.0% |
| Q2 2021 | $2,238,000 | +41.5% | 54,508 | 0.0% | 0.00% | +33.3% |
| Q1 2021 | $1,582,000 | -76.6% | 54,508 | +24.6% | 0.00% | 0.0% |
| Q4 2020 | $6,774,000 | +63.3% | 43,738 | -67.4% | 0.00% | -75.0% |
| Q3 2020 | $4,148,000 | – | 134,332 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 526,072 | $21,595,000 | 11.36% |
| Consonance Capital Management LP | 1,647,497 | $67,630,000 | 8.14% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,629,173 | $66,878,000 | 6.84% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,342,442 | $55,107,000 | 2.29% |
| Vivo Capital, LLC | 956,702 | $39,273,000 | 1.70% |
| Hudson Bay Capital Management LP | 1,878,374 | $77,107,000 | 0.93% |
| Capital International Sarl | 220,470 | $9,050,000 | 0.78% |
| Capital International, Inc./CA/ | 1,951,845 | $80,123,000 | 0.72% |
| Avidity Partners Management LP | 625,000 | $25,656,000 | 0.69% |
| INDUS CAPITAL PARTNERS, LLC | 94,678 | $3,887,000 | 0.66% |